InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Huff James Warren. Director active across 1 company, notably Reata Pharmaceuticals INC. Aggregated, 4 filings have been published. History available since 3 January 2023. The latest transaction was disclosed on 6 July 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Huff James Warren is a declarant with 4 filings in total. In the 4 sampled recent filings, covering the period from 2023-01-04 to 2023-09-26, total buy amount is EUR 0 and total sell amount is EUR 0. The modal transaction nature is Attribution, and Reata Pharmaceuticals INC is the only company mentioned, where he is listed as Chief Executive Officer.